Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-25-025135
Filing Date
2025-03-19
Accepted
2025-03-19 17:00:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 19025
2 JOINT FILING AGREEMENT ea023498801ex-a_praxis.htm EX-99.A 9284
  Complete submission text file 0001213900-25-025135.txt   30013
Mailing Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110 617-300-8460
Praxis Precision Medicines, Inc. (Subject) CIK: 0001689548 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92098 | Film No.: 25753551
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 104 FIELD POINT ROAD 2ND FLOOR GREENWICH CT 06830
Business Address 104 FIELD POINT ROAD 2ND FLOOR GREENWICH CT 06830 4752083111
Soleus Capital Master Fund, L.P. (Filed by) CIK: 0001812275 (see all company filings)

EIN.: 981413657 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G